← Leaderboards
Pascal J. Goldschmidt-Clermont
Duke University
$5,139,988
Attributed
$6,910,412
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $757.5K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$14,644,871 · 4
By mechanism
P01$7,734,459 · 1
R01$6,910,412 · 3
Top collaborators
- Enrique A Mesri9 shared
Most similar at Duke University
Same institution · by research overlap
- Micah A. Luftig$19,856,384
- Nancy L Zucker$4,510,552
- Cheryl D Bushnell$4,197,850
- Michael S Krangel$23,371,548
- Dorothy A Sipkins$8,543,606
Others in their field
Top investigators on “Prevent”
- Lawrence Corey · Fred Hutchinson Cancer Center$609,181,782
- Jeffrey P Krischer · University Of South Florida$605,511,231
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$530,065,238
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$499,311,118
- David Heimbrook · Leidos Biomedical Research, Inc.$496,394,926
Research focus
PreventCellsBaseAngiogenesisPlatelet-Derived Growth FactorMalignant NeoplasmsSignal TransductionGenesKaposi SarcomaIn VivoLesionAnti-Retroviral AgentsNew Therapeutic TargetCancer TypeChemotherapyPathogenesisGene ExpressionLeadPharmaceutical PreparationsAnimal ModelAffectGeneticAcquired Immunodeficiency SyndromeStem Cells
Grant awards (25)
Interplay Between KSHV and PDGFRA in AIDS-Kaposi's Sarcoma Oncogenesis$457,223
R01 · FY2017 · CA
Interplay Between KSHV and PDGFRA in AIDS-Kaposi's Sarcoma Oncogenesis$30,336
R01 · FY2017 · CA
Interplay Between KSHV and PDGFRA in AIDS-Kaposi's Sarcoma Oncogenesis$457,223
R01 · FY2016 · CA
Interplay Between KSHV and PDGFRA in AIDS-Kaposi's Sarcoma Oncogenesis$457,223
R01 · FY2015 · CA
ROLE OF Rac AND REACTIVE OXYGEN SPECIES IN KAPOSI'S SARCOMA VIRAL ONCOGENESIS$406,962
R01 · FY2014 · CA
ROLE OF Rac AND REACTIVE OXYGEN SPECIES IN KAPOSI'S SARCOMA VIRAL ONCOGENESIS$395,903
R01 · FY2013 · CA
ROLE OF Rac AND REACTIVE OXYGEN SPECIES IN KAPOSI'S SARCOMA VIRAL ONCOGENESIS$437,003
R01 · FY2012 · CA
ROLE OF Rac AND REACTIVE OXYGEN SPECIES IN KAPOSI'S SARCOMA VIRAL ONCOGENESIS$438,640
R01 · FY2011 · CA
ROLE OF Rac AND REACTIVE OXYGEN SPECIES IN KAPOSI'S SARCOMA VIRAL ONCOGENESIS$460,336
R01 · FY2010 · CA
Impact of Aging on Stem Cell Repair in Atherosclerosis$387,396
R01 · FY2008 · AG · contact PI
Impact of Aging on Stem Cell Repair in Atherosclerosis$293,771
R01 · FY2007 · AG · contact PI
Impact of Aging on Stem Cell Repair in Atherosclerosis$98,639
R01 · FY2007 · AG · contact PI
Impact of Aging on Stem Cell Repair in Atherosclerosis$304,521
R01 · FY2006 · AG · contact PI
Rac, Superoxide and Antioxidants in Hypertension$367,521
R01 · FY2005 · HL
Impact of Aging on Stem Cell Repair in Atherosclerosis$311,850
R01 · FY2005 · AG
Impact of Aging on Stem Cell Repair in Atherosclerosis$60,601
R01 · FY2005 · AG
Rac, Superoxide and Antioxidants in Hypertension$17,479
R01 · FY2005 · HL
Comparative Approach to Genomics of Complex Traits$2,822,554
P01 · FY2004 · HL
Rac, Superoxide and Antioxidants in Hypertension$385,000
R01 · FY2004 · HL
Impact of Aging on Stem Cell Repair in Atherosclerosis$311,850
R01 · FY2004 · AG
Impact of Aging on Stem Cell Repair in Atherosclerosis$60,935
R01 · FY2004 · AG
Comparative Approach to Genomics of Complex Traits$2,367,879
P01 · FY2003 · HL
Rac, Superoxide and Antioxidants in Hypertension$385,000
R01 · FY2003 · HL
Comparative Approach to Genomics of Complex Traits$2,544,026
P01 · FY2002 · HL
Rac, Superoxide and Antioxidants in Hypertension$385,000
R01 · FY2002 · HL